Riboflavin-modified lipo-polyplexes co-delivering CXCR4 siRNA and doxorubicin for treatment of highly metastatic cancer | Zendy

AI Assistant Blog Pricing

Open Access

Riboflavin-modified lipo-polyplexes co-delivering CXCR4 siRNA and doxorubicin for treatment of highly metastatic cancer

Publication year - 2021

Publication title -

journal of chinese pharmaceutical sciences

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.138

H-Index - 12

ISSN - 1003-1057

DOI - 10.5246/jcps.2021.03.015

Subject(s) - doxorubicin , cancer research , chemistry , riboflavin , medicine , chemotherapy , biochemistry

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Empowering knowledge with every search

About

About Careers Publisher Partners Contact Us

Learn

FAQs Blog Terms of Use Privacy Policy

Discover

Explore

Copyright Knowledge E © 2025. All Rights Reserved.